JamesRichardEshlemanJr.MD

PubMed

• High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
  Jing Zhu, Aparna Pallavajjala, Ezra G Baraban, Roy Elias, Ming-Tseh Lin, Yasser Ged, Nirmish Singla, Tamara L Lotan, Pedram Argani, James R Eshleman, Jonathan I Epstein> ;Modern Pathology. 2024 Mar 14
• Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer.
  Yohei Ando, Mohamad Dbouk, Takeichi Yoshida, Helena Saba, Elizabeth Abou Diwan, Kanako Yoshida, Ali Dbouk, Amanda L Blackford, Ming-Tseh Lin, Anne Marie Lennon, Richar...> ;Journal of Clinical Oncology. 2024 Mar 8
• ASO Visual Abstract: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery.
  Ando, Y., Blackford, A., Yoshida, T., Saba, H., Diwan, E., Yoshida, K., Sokoll, L., Dbouk, M., Eshleman, J., Burkhart, R., He, J., Goggins, M.> ;Annals of Surgical Oncology. 2024 Feb 14
• Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery.
  Yohei Ando, Mohamad Dbouk, Amanda L Blackford, Takeichi Yoshida, Helena Saba, Elizabeth Abou Diwan, Kanako Yoshida, Lori Sokoll, James R Eshleman, Richard Burkhart, Ji...> ;Annals of Surgical Oncology. 2024 May 1
• Islands of genomic stability in the face of genetically unstable metastatic cancer.
  Bowland, K., Lai, J., Skaist, A., Zhang, Y., Teh, S., Roberts, N., Thompson, E., Wheelan, S., Karchin, R., Hruban, R., Iacobuzio-Donahue, C., Eshleman, J.> ;Biorxiv. 2024 Jan 29
• Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19-9 Reference Ranges.
  Mohamad Dbouk, Toshiya Abe, Chiho Koi, Yohei Ando, Helena Saba, Elizabeth Abou Diwan, Anne MacGregor-Das, Amanda L Blackford, Evelina Mocci, Katie Beierl, Ali Dbouk, J...> ;Clinical Cancer Research. 2023 Oct 13
• CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers.
  Selina Shiqing K Teh, Kirsten Bowland, Alexis Bennett, Eitan Halper-Stromberg, Alyza Skaist, Jacqueline Tang, Fidel Cai, Antonella Macoretta, Hong Liang, Hirohiko Kami...> ;Biorxiv. 2023 Oct 10
• 1 citations
  MLH1 Loss in Primary Prostate Cancer.
  Sanaz Nourmohammadi Abadchi, Laura A Sena, Emmanuel S Antonarakis, Colin C Pritchard, James R Eshleman, Eric Q Konnick, Stephen J Salipante, Eugene Shenderov, Tamara L...> ;JCO Precision Oncology. 2023 May 1
• Mechanism of delayed cell death following simultaneous CRISPR-Cas9 targeting in pancreatic cancers.
  Selina Shiqing K Teh, Eitan Halper-Stromberg, Laura Morsberger, Alexis Bennett, Kirsten Bowland, Alyza Skaist, Fidel Cai, Hong Liang, Ralph H Hruban, Nicholas J Robert...> ;Biorxiv. 2023 Apr 5
• 3 citations
  Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion.
  Yea Ji Jeong, Hildur Knutsdottir, Fatemeh Shojaeian, Michael G Lerner, Maria F Wissler, Elodie Henriet, Tammy Ng, Shalini Datta, Bernat Navarro-Serer, Peter Chianchian...> ;The Journal of Clinical Investigation. 2023 Apr 17
• 2 citations
  IVT generation of guideRNAs for Cas9-enrichment Nanopore Sequencing.
  Timothy Gilpatrick, Josh Zhiyong Wang, David Weiss, Alexis L Norris, James Eshleman, Winston Timp> ;Biorxiv. 2023 Feb 7
• Analytical Validation ofGenotyping.
  Marija Debeljak, Stacy Riel, Ming-Tseh Lin, James R Eshleman, Channing J Paller> ;Methods and Protocols. 2022 Dec 31
• 6 citations
  Optimizing Insertion and Deletion Detection Using Next-Generation Sequencing in the Clinical Laboratory.
  Catherine G Fischer, LiQun Jiang, Aparna Pallavajjala, Ming-Tseh Lin, James R Eshleman, Craven, K.> ;The Journal of Molecular Diagnostics. 2022 Dec 1
• 5 citations
  Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
  Aparna Pallavajjala, Lisa Haley, Victoria Stinnett, Emily Adams, Roshni Pallavajjala, Jialing Huang, Laura Morsberger, Melanie Hardy, Patty Long, Christopher D Gocke, ...> ;Human Pathology. 2022 Aug 1
• 1 citations
  Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets.
  Catherine G Fischer, Aparna Pallavajjala, LiQun Jiang, Valsamo Anagnostou, Jessica Tao, Emily Adams, James R Eshleman, Christopher D Gocke, Ming-Tseh Lin, Elizabeth A ...> ;Clinical Cancer Research. 2022 Jun 1
• 4 citations
  Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance.
  Hirokazu Kimura, Raymond M Paranal, Neha Nanda, Laura D Wood, James R Eshleman, Ralph H Hruban, Michael G Goggins, Alison P Klein, , Nicholas J Roberts> ;Elife. 2022 Jan 10
• 2 citations
  A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones.
  Wei Liu, Yuyan Wang, Hongchan Huang, Nadege Fackche, Kristen Rodgers, Beverly Lee, Wasay Nizam, Hamza Khan, Zhihao Lu, Xiangqian Kong, Yanfei Li, Naixin Liang, Xin Zha...> ;Non-Coding RNA. 2021 Dec 16
• 4 citations
  Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.
  Wissam Dahoud, Jesse Handler, Vamsi Parimi, Christian F. Meyer, Stephanie L. Wethington, James R. Eshleman, Russell Vang, Brigitte M. Ronnett, Deyin Xing> ;International Journal of Gynecological Pathology. 2021 Dec 3
• 10 citations
  Validation of long mononucleotide repeat markers for detection of microsatellite instability
  John H. Lin, Suping Chen, Aparna Pallavajjala, Liana B. Guedes, Tamara L. Lotan, Jeffery W. Bacher, James R. Eshleman> ;The Journal of Molecular Diagnostics. 2021 Dec 2
• 1 citations
  Double PIK3CA Alterations and Parallel Evolution in Colorectal Cancers.
  Ming-Tseh Lin, Gang Zheng, Erika F. Rodriguez, Li Hui Tseng, Vamsi Parini, Rena Xian, Ying Zou, Christopher D. Gocke, James R. Eshleman> ;American Journal of Clinical Pathology. 2021 Sep 14
• CloneRetriever: An Automated Algorithm to Identify Clonal B and T Cell Gene Rearrangements by Next-Generation Sequencing for the Diagnosis of Lymphoid Malignancies.
  Eitan Halper-Stromberg, Chad M. McCall, Lisa Haley, Ming-Tseh Lin, Samantha L. Vogt, Christopher D. Gocke, James R. Eshleman, Wendy Stevens, Neil A. Martinson, Marta E...> ;Clinical Chemistry. 2021 Nov 1
• 11 citations
  IDH1 and IDH2 Mutations in Colorectal Cancers.
  Jialing Huang, Li Hui Tseng, Vamsi Parini, Parvez M. Lokhandwala, Aparna Pallavajjala, Erika F. Rodriguez, Rena Xian, Liam Chen, Christopher D. Gocke, James R. Eshlema...> ;American Journal of Clinical Pathology. 2021 Oct 13
• 1 citations
  Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures.
  Aistė Gulla, Egidijus Kazlauskas, Hong Liang, Kęstutis Strupas, V. Petrauskas, Daumantas Matulis, James R. Eshleman> ;Pancreas. 2021 Apr 1
• 31 citations
  Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial
  Eugene Shenderov, Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan, Donna Dowling, Rana Harb, Joseph D. Schonhoft, Adam Jendrisak, Michael A. Carducci, Mar...> ;The Prostate. 2021 Feb 26
• 5 citations
  Pancreatic cancer pathology viewed in the light of evolution.
  Michaël Noë, Seung-Mo Hong, Laura D. Wood, Elizabeth D. Thompson, Nicholas J. Roberts, Michael Goggins, Alison P. Klein, James R. Eshleman, Scott E. Kern, Ralph H. Hruban> ;Cancer Metastasis Reviews. 2021 Feb 8
• Join now to see all

Journal Articles

• Clinical Validation of Coexisting Driver Mutations in Colorectal Cancers  
  Junaid Ibrahim, James R Eshleman, Gang Zheng, Christopher D Gocke, Rena Xian, ScienceDirect